Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Pharmaceuticals Newsletter 2001, No. 01
(2001; 16 pages)
Table of Contents
View the documentEditorial
View the documentRegulatory matters
View the documentSafety of medicines
View the documentReview of ADRs
View the documentMedication errors
View the documentFeature
 

WHO Pharmaceuticals Newsletter 2001, No. 01

prepared in collaboration with the WHO Collaborating Centre for International Drug Monitoring

The aim of this Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on information received from our network of “drug information officers” and other sources such as specialized bulletins and journals, as well as partners in WHO. Information on adverse drug reactions is provided by the WHO Collaborating Centre for International Drug Monitoring. The information is produced in the form of résumés in English full texts of which may be obtained on request from:

Quality Assurance and Safety: Medicines, EDP-HTP,
World Health Organization
1211 Geneva 27
Switzerland
E-mail address: <mailto:qsm@who.int>
Fax: +41 22 791 4730.

Further information on adverse reactions may be obtained from:

WHO Collaborating Centre for International Drug Monitoring
Stora Torget 3
S-753 20 Uppsala
Sweden

Tel: 46-18-65.60.60
Fax: 46-18-65.60.80
E-mail: sten.olsson@who-umc.org
Internet: http://www.who-umc.org

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014